X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (211) 211
humans (203) 203
atrial fibrillation (189) 189
cardiac & cardiovascular systems (151) 151
anticoagulants (127) 127
warfarin (125) 125
aged (124) 124
stroke (123) 123
female (119) 119
male (119) 119
risk factors (115) 115
abridged index medicus (100) 100
anticoagulants - therapeutic use (82) 82
middle aged (77) 77
peripheral vascular disease (75) 75
aged, 80 and over (72) 72
atrial fibrillation - drug therapy (71) 71
stroke - prevention & control (69) 69
anticoagulants - adverse effects (67) 67
atrial fibrillation - complications (65) 65
cardiac arrhythmia (62) 62
warfarin - therapeutic use (62) 62
anticoagulation (60) 60
anticoagulants - administration & dosage (57) 57
cardiovascular (57) 57
treatment outcome (57) 57
drug therapy (56) 56
hemorrhage (54) 54
warfarin - adverse effects (51) 51
hematology (48) 48
risk (48) 48
hemorrhage - chemically induced (47) 47
internal medicine (46) 46
stroke - etiology (45) 45
international normalized ratio (44) 44
medicine, general & internal (43) 43
mortality (43) 43
prevention (43) 43
medical and health sciences (41) 41
medicin och hälsovetenskap (41) 41
warfarin - administration & dosage (41) 41
care and treatment (39) 39
therapy (39) 39
antithrombotic therapy (38) 38
risk assessment (36) 36
stroke prevention (34) 34
thromboembolism (34) 34
administration, oral (33) 33
management (32) 32
risk-factors (32) 32
atrial-fibrillation (31) 31
clinical medicine (30) 30
analysis (29) 29
dosage and administration (28) 28
oral anticoagulation (28) 28
atrial fibrillation - epidemiology (27) 27
follow-up studies (27) 27
incidence (27) 27
kardiologi (27) 27
thromboembolism - prevention & control (27) 27
apixaban (26) 26
cardiac and cardiovascular systems (26) 26
cardiology (26) 26
klinisk medicin (26) 26
patient outcomes (26) 26
patients (26) 26
age factors (25) 25
bleeding (25) 25
dabigatran (25) 25
prognosis (25) 25
prospective studies (25) 25
stroke - epidemiology (25) 25
thrombosis (25) 25
atrial fibrillation - diagnosis (24) 24
cohort studies (24) 24
article (23) 23
predicting stroke (23) 23
time factors (23) 23
complications and side effects (22) 22
medical research (22) 22
registries (22) 22
atrial fibrillation - blood (21) 21
medicine & public health (21) 21
united states (21) 21
united states - epidemiology (21) 21
adult (20) 20
bleeding complications (20) 20
atrial fibrillation - physiopathology (19) 19
retrospective studies (19) 19
age (18) 18
intracranial hemorrhage (18) 18
medicine, experimental (18) 18
outcomes (18) 18
atrial fibrillation - therapy (17) 17
biomarkers (17) 17
dose-response relationship, drug (17) 17
fibrinolytic agents - therapeutic use (17) 17
hemorrhage - epidemiology (17) 17
aspirin (16) 16
comorbidity (16) 16
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Thrombosis and Haemostasis, ISSN 0340-6245, 12/2018, Volume 118, Issue 12, pp. 2018 - 2019
Journal Article
Lancet, The, ISSN 0140-6736, 2016, Volume 387, Issue 10035, pp. 2302 - 2311
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2014, Volume 63, Issue 20, pp. 2141 - 2147
Journal Article
Journal Article
American Heart Journal, ISSN 0002-8703, 2010, Volume 159, Issue 3, pp. 331 - 339
Atrial fibrillation (AF) is associated with increased risk of stroke that can be attenuated with vitamin K antagonists (VKAs). Vitamin K antagonist use is... 
Cardiovascular | XIMELAGATRAN | CARDIAC & CARDIOVASCULAR SYSTEMS | ANTICOAGULATION CONTROL | WARFARIN | ANTITHROMBOTIC THERAPY | PREVENTION | RISK | HEPARIN | ASPIRIN | FACTOR XA INHIBITOR | ANTIPLATELET THERAPY | Pyrazoles - therapeutic use | Factor Xa Inhibitors | Follow-Up Studies | Humans | Middle Aged | Warfarin - adverse effects | Warfarin - therapeutic use | Young Adult | Fibrinolytic Agents - adverse effects | Thromboembolism - prevention & control | Fibrinolytic Agents - therapeutic use | Adult | Pyrazoles - adverse effects | Stroke - prevention & control | Atrial Fibrillation - drug therapy | Anticoagulants - therapeutic use | Treatment Outcome | Anticoagulants - adverse effects | International Normalized Ratio | Adolescent | Aged | Pyridones - therapeutic use | Hemorrhage - chemically induced | Research Design | Pyridones - adverse effects | Stroke (Disease) | Clinical trials | Medical colleges | Warfarin | Atrial fibrillation | Risk factors | Health care | Anticoagulants | Cardiac arrhythmia | Stroke | Mortality | Thrombosis | Joint replacement surgery | Disease prevention | Blood platelets | Biomarkers | Blood pressure | Diabetes | Drug therapy | Drug dosages | Index Medicus | Abridged Index Medicus | Pyrazoles | Pyridones | Factor Xa | Fibrinolytic Agents | Hemorrhage | Life Sciences | Thromboembolism | Atrial Fibrillation | Medical and Health Sciences | MEDICINE | Medicin och hälsovetenskap | MEDICIN
Journal Article
Journal Article
American Heart Journal, ISSN 0002-8703, 2015, Volume 170, Issue 1, pp. 141 - 148.e1
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 07/2019, Volume 73, Issue 25, pp. 3309 - 3311
In this issue of the Journal, Lee et al.(7)report their findings on the efficacy and safety of direct oral anticoagulants among individuals with atrial... 
atrial fibrillation | non-vitamin K oral antagonist | liver disease | cirrhosis | direct oral anticoagulant | warfarin | Hypertension | Anticoagulants | Cardiac arrhythmia | Enzymes | Stroke | Liver diseases | Laboratories | Metabolism | Drug dosages
Journal Article